Back to Search
Start Over
The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study
- Source :
- Frontiers in Endocrinology, Vol 12 (2021), Frontiers in Endocrinology
- Publication Year :
- 2021
- Publisher :
- Frontiers Media SA, 2021.
-
Abstract
- AimsNon-alcoholic fatty liver disease (NAFLD) has a dynamic disease course, therefore repeated measurements of NAFLD status could have benefits rather than single one. The aim of this study was to investigate the effects of persistent NAFLD on the incidence of myocardial infarction (MI) and stroke and all-cause mortality by using repeated measurement of fatty liver index (FLI).MethodsAbout 3 million subjects who had undergone the health screening four times from 2009 until 2013 were included. NAFLD was defined as an FLI ≥60. FLI points were defined as the number of times participants meeting the criteria of NAFLD (0–4). Outcomes included all-cause mortality, MI, and stroke.ResultsThe higher the FLI points, the higher the risk of all-cause mortality, MI, and stroke (P for trend P < 0.001), incidence of MI (aHR, 1.3; 95% CI, 1.21–1.40; P < 0.001), and stroke (aHR, 1.27; 95% CI, 1.19–1.37; P < 0.001) after adjustment for age, sex, smoking, alcohol consumption, income, hypertension, dyslipidemia, diabetes, body mass index, and physical activity. When the 1st and the last FLI were compared, the “incident NAFLD” group had a higher risk for death compared to the “no NAFLD” group (aHR, 1.46; 95% CI, 1.37–1.55), and the “regression of NAFLD” group had a decreased risk for death compared to the “persistent NAFLD” group (aHR, 0.83; 95% CI, 0.77–0.89).ConclusionRepeated evaluations of NAFLD status based on FLI measurements could help physicians identify higher-risk groups in terms of mortality, MI, and stroke. The association between FLI worsening or improvement and outcomes also suggests clinical benefits of the prevention and treatment of NAFLD.
- Subjects :
- Adult
Male
Risk
medicine.medical_specialty
Endocrinology, Diabetes and Metabolism
Myocardial Infarction
Disease
Severity of Illness Index
lcsh:Diseases of the endocrine glands. Clinical endocrinology
Body Mass Index
Young Adult
03 medical and health sciences
Endocrinology
0302 clinical medicine
Liver Function Tests
Non-alcoholic Fatty Liver Disease
Risk Factors
cardiovascular disease
Internal medicine
Diabetes mellitus
Republic of Korea
medicine
Humans
non-invasive test
030212 general & internal medicine
Myocardial infarction
Stroke
Aged
Retrospective Studies
Original Research
fatty liver
lcsh:RC648-665
business.industry
Incidence
hepatic steatosis
Incidence (epidemiology)
Fatty liver
Middle Aged
medicine.disease
mortality
digestive system diseases
Treatment Outcome
Cardiovascular Diseases
Regression Analysis
Female
030211 gastroenterology & hepatology
business
Body mass index
Dyslipidemia
Subjects
Details
- ISSN :
- 16642392
- Volume :
- 12
- Database :
- OpenAIRE
- Journal :
- Frontiers in Endocrinology
- Accession number :
- edsair.doi.dedup.....da421d8bbb8230844338f20d4dc7dc7e
- Full Text :
- https://doi.org/10.3389/fendo.2021.638615